SOPHARMA (SPH): Current report 35 buy back 14032013 - raport 35
Raport ESPI
UNI - EN REPORT No 35/2013
Podstawa prawna:
Art. 56 ust. 1 pkt 1 Ustawy o ofercie - informacje poufne
The Board of Directors of SOPHARMA AD (the "Company") hereby informs that from 7 March 2013 up to and including 13 March 2013 the Company bought 16080 own shares representing 0.012% of the share capital of the Company, to the total value of BGN 36047.53 on the Bulgarian Stock Exchange. The average price per share was BGN 2.24.
The shares have been bought on the basis of the general meeting resolution No. 7 of 23.06.2010.
The total number of own shares after these transactions is 3637179, representing 2.755% of the share capital of the Company.
Annexes:
File;
